Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Inari Medical Inc
(NQ:
NARI
)
42.98
-0.25 (-0.59%)
Streaming Delayed Price
Updated: 2:12 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inari Medical Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
NARI INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Inari Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 15, 2024
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
INARI MEDICAL SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI
May 14, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
INARI ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Inari Medical, Inc. and Encourages Investors to Contact the Firm
May 14, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
What 8 Analyst Ratings Have To Say About Inari Medical
April 12, 2024
Via
Benzinga
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc. (NARI) Investors
May 14, 2024
From
Kirby McInerney LLP
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Inari Medical, Inc. with Losses to Contact the Firm
May 14, 2024
From
Schall Law
Via
GlobeNewswire
INARI MEDICAL, INC. (NASDAQ: NARI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Inari Medical, Inc.
May 14, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Forecasting The Future: 7 Analyst Projections For Inari Medical
March 22, 2024
Via
Benzinga
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
May 14, 2024
From
Rosen Law Firm
Via
Business Wire
Grant & Eisenhofer Files Class Action Lawsuit Against Inari Medical, Inc. on Behalf of Institutional Investor
May 13, 2024
From
Grant & Eisenhofer P.A.
Via
Business Wire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
May 07, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference
May 06, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
May 03, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
May 01, 2024
Via
Benzinga
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 01, 2024
Via
Benzinga
Why Pinterest Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
May 01, 2024
Via
Benzinga
NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q1 2024
April 30, 2024
NARI stock results show that Inari Medical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Inari Medical Reports First Quarter 2024 Financial Results
April 30, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 22, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 19, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Inari Medical to Announce First Quarter 2024 Financial Results
April 17, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 15, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
April 11, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 11, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
April 02, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Market Cap Game Show: Andy Cross vs. Bill Mann
March 30, 2024
Join the "Rule Breaker Investing" fun.
Via
The Motley Fool
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
March 20, 2024
NEW YORK, NY - (NewMediaWire) - March 20, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)...
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
March 20, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
March 19, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
March 19, 2024
NEW YORK, NY - (NewMediaWire) - March 19, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)...
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.